Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
The somatic genomic landscape of glioblastoma
